The Evolving Research Landscape of Methamphetamine-Associated Heart Failure

Upon completion of this program, attendees should be able to:

• Appreciate the challenges inherent to the study of methamphetamine-associated heart failure
• Discover the breadth of research on methamphetamine-associated heart failure happening at the University of Washington and beyond
• Outline the next steps to advance the study of methamphetamine-associated heart failure

The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Washington School of Medicine designates this live activity for a maximum of 36.0 AMA PRA Category 1 Credits™. 

Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit)

To request disability accommodation, contact the Office of the Disability Services Office at least ten days in advance of the event at 206-543-6450 (voice), 206-543-6452 (TTY), 206-685-7264 (FAX), dso@u.washington.edu.

The members of the Grand Rounds Committee have no disclosures relevant to this series